Why a Life Science Speaker Belongs on Your Stage

Longevity has moved from the wellness fringe to the main agenda. It now shows up in leadership meetings, HR strategy, and conference programmes, driven by ageing workforces, rising healthcare costs, and a run of genuine scientific progress. Your audience has seen the headlines about reversing ageing and the influencers selling supplements. What most of them lack is someone credible to explain which parts are real. That gap is exactly why a life science speaker earns their place on the bill.

Here is what the field looks like right now, and how to think about booking for it.

The shift from lifespan to healthspan

The old question was how long we can live. The question researchers care about now is healthspan: the number of years you stay healthy, active, and free of serious disease. Adding years of frailty helps no one. Adding years of vitality changes personal quality of life and national healthcare budgets at the same time.

Underneath that shift is a change in how science views ageing itself. Rather than simple wear and tear, ageing is now understood as a set of specific, measurable biological processes, often called the hallmarks of ageing. Cells stop dividing but refuse to die and leak inflammation. The protective caps on our chromosomes shorten like the plastic tip fraying off a shoelace. The chemical “software” that tells genes when to switch on and off gets scrambled. Once you can name the mechanisms, you can start trying to slow them. That is the premise the entire field rests on.

What the science actually says right now

Progress in 2025 and into 2026 falls into a few clear groups, which makes it far easier to present to a general audience.

The fastest movement is coming from existing drugs being tested for ageing. Rapamycin has extended lifespan by 15 to 20 percent in animal studies and is now in early human trials. GLP-1 medicines, the class behind Ozempic, are being reframed as possible longevity drugs after research linked them to lower all-cause mortality. Diabetes drugs called SGLT2 inhibitors produced a surprising 2025 finding of telomere lengthening, not just slower shortening.

Hormone therapy is being rehabilitated too. In 2025 the US FDA removed its longstanding “black box” warning from menopausal hormone replacement therapy, reflecting evidence of real benefits when started at the right time.

The frontier, and the source of most of the bold headlines, is cellular reprogramming. Harvard’s David Sinclair has shown it is possible to partially reset the biological age of cells in animals, even restoring sight in blind mice, and the first human trials are beginning.

Sitting quietly beneath all of it is the least glamorous finding and the one with the strongest evidence: exercise, sleep, nutrition, and social connection still do more for a long, healthy life than any pill on the market. Dan Buettner’s Blue Zones research documents communities with clusters of healthy hundred-year-olds who got there through daily habits, not biotech.

The hype problem, and why it works in your favour

For every real result, there is an inflated claim. Companies promise to make you “three years younger” using ageing clocks that often disagree with each other. Regulators have already stepped in, from the US FTC challenging anti-ageing marketing to the UK Advertising Standards Authority banning certain collagen adverts.

No one embodies the extreme end better than Bryan Johnson, the tech entrepreneur who sold Braintree and now spends around two million dollars a year on his Project Blueprint regimen.

The regimen runs to hundreds of supplements, constant biometric tracking, and a strict plant-based diet. For a time it also included plasma transfusions from his teenage son, which he dropped after reporting no benefit.

Johnson has said his goal is to live to 2140. Netflix released a documentary on him this year, Don’t Die: The Man Who Wants to Live Forever, and scientists remain openly sceptical of his results.

The Bryan Johnson story is useful precisely because it is so extreme. It shows an audience how far the culture now goes, and it sets up the more grounded point: the evidence still favours the basics over the gadgets.

A good speaker uses that contrast to earn trust. Audiences are curious and confused in roughly equal measure, and the value of an expert on stage is that they separate the credible science from the noise in real time. That is a rare and genuinely useful thing to give a room.

Why this is now a leadership issue

Longevity used to belong to the wellness committee. Healthcare is now the fastest-growing cost line in most corporate budgets, and the standard playbook of better plan design, narrower networks, and higher deductibles has delivered diminishing returns. A different conversation is happening in laboratories and longitudinal studies, built on a different question: what if the variable to manage is not claims but biological ageing itself.

That is the case researchers like Nir Barzilai, Eric Verdin, and Murali Doraiswamy are building the evidence for, and increasingly bring straight to leadership teams. Barzilai directs the Institute for Aging Research at Albert Einstein College of Medicine and has spent decades studying centenarians to understand why some people age slowly and others don’t. He separates what the data supports from what is marketing, which is exactly what health, insurance, and workforce planning leaders need. Verdin, President and CEO of the Buck Institute for Research on Aging, makes the economic argument directly: healthspan interventions compress the years of late-life illness, which lowers costs and keeps people productive for longer. Doraiswamy, Professor of Psychiatry and Medicine at Duke, brings the same thinking to brain health specifically, showing CHROs and benefits leaders how cognitive resilience belongs in talent strategy rather than sitting off to the side as a wellness perk.

A speaker who can connect that biology to workforce planning, benefits strategy, and productivity hands a leadership audience something they can act on the next morning.

There is an emotional case as well. A lot of future-facing conference content leaves people anxious about disruption. Longevity is one of the few big topics that sends an audience home hopeful and personally motivated, thinking about their own habits and the years ahead. For an organiser trying to close an event on a high, that lift is worth a great deal.

Choosing the right speaker for your audience

Life science is unusually versatile as a theme because the speaker pool is so varied. The trick is matching the type of expert to the room.

For leadership, HR, and insurance audiences focused on cost and workforce risk, a geroscience researcher such as Nir Barzilai or Eric Verdin makes the economic case directly, translating ageing research into what it means for claims and productivity. For brain health specifically, Dr Marc Milstein is a strong fit. He holds a PhD in Biological Chemistry from UCLA and wrote the number one bestseller The Age-Proof Brain, and his talk on boosting memory and lowering dementia risk speaks directly to this topic. Dr Sabina Brennan, a neuroscientist and former director of a brain health and dementia research programme at Trinity College Dublin, brings the same science into a broader resilience and high-performance keynote, suiting an all-staff or wellness audience. For a more research-led take on neurodegeneration, Baroness Susan Greenfield is a pioneering neuroscientist and founder of the biotech company Neuro-Bio, developing new Alzheimer’s treatments from her own research into novel brain mechanisms, well suited to scientific, pharma, or academic audiences. On the nutrition side, Dr Megan Rossi, the Gut Health Doctor and a King’s College London research fellow, has a session called Age-Proof Your Gut To Future-Proof Your Health, connecting diet directly to healthy ageing. For leadership and innovation events, a futurist such as Peter Diamandis, founder of XPRIZE, connects ageing to AI, gene therapy, and the economics of longer lives.

It is also worth remembering that a life science speaker can range well beyond longevity, into AI-driven drug discovery, CRISPR gene editing, and precision medicine. The breadth means the same broad theme can headline a medical conference, an HR summit, a leadership away day, or an after-dinner slot, simply by choosing a different voice.

Book a life science speaker with PepTalk

The science is moving quickly, the public conversation is loud and confusing, and your audience wants a trusted guide through it. Browse PepTalk’s Age and Ageing speakers for the full roster, from brain health and gut health experts to demographers and futurists.

Tell us your audience and your date, and we will match you with the right speaker. Email bookings@getapeptalk.com or call +44 20 3835 2929 to book.